Effects of morphine treatment and withdrawal on striatal and limbic monoaminergic activity and ascorbic acid oxidation in the rat

Brain Research

Volumn 723, Issue 1-2, 1996, Pages 154-161

  Desole, Maria S ^a   Esposito, Giovanni ^a   Fresu, Luigia ^a   Migheli, Rossana ^a   Enrico, Paolo ^a   Mura, Maria A ^a   De Natale, Guglielmo ^a   Miele, Egidio ^a   Miele, Maddalena ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

ascorbic acid oxidation; dopamine metabolism; excitotoxicity; limbic forebrain; morphine; striatum; withdrawal

Indexed keywords

4 AMINOBUTYRIC ACID; ASCORBIC ACID; DOPAMINE; GLUTAMIC ACID; MORPHINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DRUG WITHDRAWAL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMBIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030013519     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00235-1     Document Type: Article

References (43)

1. Aghajanian, G.K., Kogan, J.H. and Moghaddam, B., Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study, Brain Res., 636 (1994) 126-130.
2. Ahtee, L., Attila, L.M.J., Carlson, K.R. and Haikala, H., Changes in brain monoamine metabolism during withdrawal from chronic oral self-administration of morphine and in response to a morphine challenge in the withdrawal state, J. Pharmacol. Exp. Ther., 249 (1989) 303-310.
3. Akaoka, H. and Aston-Jones, G., Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input, J. Neurosci., 11 (1991) 3830-3939.
4. Andén, N.E., Grabowska-Andén, M., Lindgren, S. and Thornström, U., Synthesis rate of dopamine: difference between corpus striatum and limbic system as a possible explanation of variations in reactions to drugs, Naunyn-Schmiedeberg's Arch. Pharmacol., 323 (1983) 193-198.
5. Attila, L.M.J. and Ahtee, L., Retardation of cerebral dopamine turnover after morphine withdrawal and its enhanced acceleration by acute morphine administration in rats, Naunyn-Schmiedeberg's Arch. Pharmacol., 327 (1984) 201-207.
6. Becker, B.B., Towards the physiological function of uric acid, Free Radic. Biol. Med., 14 (1993) 615-631.
7. Bondy, S.C. and LeBel, C.P., The relationship between excitotoxicity and oxidative stress in the central nervous system, Free Radic. Biol. Med., 14 (1993) 633-642.
8. Carboni, E., Imperato, A., Perezzani, L. and Di Chiara, G., Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats, Neuroscience, 28 (1989) 652.
9. De Angeli, L., Ascorbic acid and atypical antipsychotic drugs: modulation of aminopeptine-induced behavior in mice. Brain Res., 670 (1995) 303-307.
10. Desole, M.S., Esposito, G., Migheli, R., Fresu, L., Sircana, S., Miele, M., De Natale, G. and Miele, E., Allopurinol protects against manganese-induced oxidative stress in the striatum and in the brainstem of the rat, Neurosci. Lett., 182 (1995) 73-76.
11. Desole, M.S., Miele, M., Enrico, P., Fresu, L., Esposito, G., De Natale, G. and Miele, E., The effects of cortical ablation on D-amphetamine-induced changes in striatal dopamine turnover and ascorbic acid catabolism in the rat. Neurosci. Lett., 139 (1992) 29-33.
12. Diliberto, E.J., Menniti, F.S., Knoth, J., Danield, A., Kizer, J.S. and Viveros, O.H., Tissue, subcellular and submitochondrial distribution of semidehydroascorbate reductase: possible role of semidehydroascorbate reductase in cofactor regeneration, J. Neurochem., 39 (1982) 563-568.
13. Gunne, L.H., Catecholamines and 5-hydroxytryptamine in morphine tolerance and withdrawal, Acta Physiol. Scand., 58 (1963) 1-19.
14. Globus, M.Y.T., Busto, R., Dietrich, W.D., Martinez, E., Valdez, I. and Ginsbert, M.D., Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid: studies by intracerebral microdialysis, J. Neurochem., 51 (1991) 1455-1464.
15. Hong, M., Milne, B. and Jhamandas, K., Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute morphine: an in vivo voltammetric study in the rat locus coeruleus, Brain Res., 623 (1993) 131-141.
16. Honkanen, A., Piepponen, T.P. and Ahtee, L., Morphine-stimulated metabolism of striatal and limbic dopamine is dissimilarly sensitized in rats upon withdrawal from chronic morphine treatment, Neurosci. Lett., 180 (1994) 119-122.
17. Hughes, R.E., The use of homocysteine in the estimation of dehydroascorbate, Biochem. J., 64 (1956) 203-208.
18. Johnston, P.A. and Chahl, L.A., Chronic treatment with ascorbic acid inhibits the morphine withdrawal response in guinea-pigs, Neurosci. Lett., 135 (1992) 23-37.
19. Khanna, N.C. and Sharma, S.K., Megadoses of vitamin C prevent the development of tolerance and physical dependence on morphine in mice, Life Sci., 33 (1983) 401-404.
20. Koob, G.F., Drugs of abuse: anatomy, pharmacology and function of reward pathways, Trends Pharmacol. Sci., 13 (1992) 177-184.
21. Lam, D.K.C. and Daniel, P.M., The influx of ascorbic acid into the rat brain, Q. J. Exp. Physiol., 71 (1986) 483-490.
22. Libby, A.F. and Stone L., The hypoascorbemia-kwashiorkor approach to drug addiction therapy: a pilot study, J. Orthomol. Psychiat., 6 (1977) 300-308.
23. Majewska, M.D., Bell, J.A. and London, E.D., Regulation of NMDA receptor by redox phenomena: inhibitory role of ascorbate, Brain Res., 537 (1990) 328-332.
24. Marek, P., Ben-Eliyahu, S., Gold, M. and Liebeskind, J.C., Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat, Brain Res., 547 (1991) 77-81.
25. Miele, M., Boutelle, M.G. and Fillenz, M., Quantitative study of brain ascorbate. In A. Luillot, T. Durkin, U. Spampinato and M. Cador (Eds.), Monitoring Molecules in Neuroscience, Universities of Bordeaux I and II, Bordeaux, 1994, pp. 19-20.
26. Miele, M., Boutelle, M.G. and Fillenz, M., The physiologically-induced release of ascorbate in rat brain is dependent on impulse traffic, calcium influx and glutamate uptake, Neuroscience, 62 (1994) 87-91.
27. Miele, M., Enrico, P., Esposito, G., Fresu, L., Migheli, R., De Natale, G. and Desole, M.S., Cortical ablation and drug-induced changes in striatal ascorbic acid oxidation and behavior in the rat, Pharmacol. Biochem. Behav., 50 (1995) 1-7.
28. Niki, E., Action of ascorbic acid as a scavenger of active and stable oxygen radicals, Am. J. Clin. Nutr., 54 (1991) 1119S-1124S.
29. Pierce, R.C., Clemens, A.J., Shapiro, L.A. and Rebec, G.V., Repeated treatment with ascorbate or haloperidol, but not clozapine, elevates extracellular ascorbate in the neostriatum of freely moving rats, Psychopharmacology, 116 (1994) 103-109.
30. Rebec, G.V. and Pierce, C.P., A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission, Prog. Neurobiol., 43 (1994) 537-565.
31. Renno, W.M., Mullet, M.A. and Beitz, A.J., Systemic morphine reduces GABA release in the lateral but not the medial portion of the midbrain periaqueductal gray of the rat, Brain Res., 594 (1992) 221-232.
32. Roginsky, V.A., Barsukova, T.K., Bruchelt, G. and Stegmann, H.B., Interaction of catecholamines and 6-hydroxydopamine with ascorbate during autoxidation, Pharmacol. Res., 31 (Suppl.) (1995) 141.
33. Rossetti, Z.L., Hmaidan, Y. and Gessa, G.L., Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rat. Eur. J. Pharmacol., 221 (1992) 227-234.
34. Saller, C.S. and Czupryna, M., γ-Aminobutyric acid, glutamate, glycine and taurine analysis using reversed-phase high-performance liquid chromatography and ultraviolet detection of dansyl chloride derivatives, J. Chromatogr., 487 (1989) 167-175.
35. Sevanian, A., Davies, K.J.A. and Hochstein, P., Serum urate as an antioxidant for ascorbic acid. Am. J. Clin. Nutr., 54 (1991) 129S-134S.
36. Shenk, J.O., Miller, E., Gaddis, E. and Adams, R.N., Homeostatic control of ascorbate concentrations in CNS extracellular fluid. Brain Res., 253 (1982) 353-356.
37. Spector, R., Penetration of ascorbic acid from cerebrospinal fluid into brain, Exp. Neurol., 72 (1981) 645-653.
38. Spina, M.B. and Cohen, G., Dopamine turnover and glutathione oxidation: implication for Parkinson's disease, Proc. Natl. Acad. Sci. USA, 87 (1989) 1398-1400.
39. Tanganelli, S., Antonelli, T., Morari, M. Bianchi, C. and Beani, L., Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs, Neurosci. Lett., 122 (1991) 270-272.
40. Tao, R. and Auerbach, S.B., Increased extracellular serotonin in rat brain after systemic or intraraphe administration of morphine, J. Neurochem., 63 (1994) 517-524.
41. Trujillo, K.A. and Akil, H., Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801, Science, 251 (1991) 85-87.
42. Wood, P.L., Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differences, Peptides, 4 (1983) 595-601.
43. Zhang, T., Feng, Y., Rockhold, R.W. and Ho, I.K., Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat, Life Sci., 55 (1994) 25-31.